UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

Journal of Virology, 2002-08, Vol.76 (15), p.7398-7406

2002

Volltextzugriff (PDF)

Distribution of HLA‐B alleles in a Ugandan HIV‐infected adult population: NORA pharmacogenetic substudy of DART

Tropical medicine & international health, 2011-02, Vol.16 (2), p.200-204

2011

Volltextzugriff (PDF)

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial

Antiviral therapy, 2010-01, Vol.15 (8), p.1115-1124

2010

Volltextzugriff (PDF)

HIV type 1 protease cleavage site mutations and viral fitness : Implications for drug susceptibility phenotyping assays

AIDS research and human retroviruses, 2000-08, Vol.16 (12), p.1149-1156

2000

Volltextzugriff (PDF)

Identification of Cross-reacting Glycoproteins of Four Herpesviruses by Western Blotting

Journal of general virology, 1985-09, Vol.66 (9), p.2039-2044

1985

Volltextzugriff (PDF)

Expression of TAR RNA-Binding Protein in Baculovirus and Co-Immunoprecipitation with Insect Cell Protein Kinase

Journal of biomedical science, 1995-04, Vol.2 (4), p.322-329

1995

Volltextzugriff (PDF)

Expression of TAR RNA-Binding Protein in Baculovirus and Co-Immunoprecipitation with Insect Cell Protein Kinase

Journal of biomedical science, 1995-10, Vol.2 (4), p.322-329

1995

Volltextzugriff (PDF)

Antigenic and biochemical analysis of gB of herpes simplex virus type 1 and type 2 and of cross-reacting glycoproteins induced by bovine mammillitis virus and equine herpesvirus type 1

Journal of general virology, 1985-02, Vol.66 (2), p.231-247

1985

Volltextzugriff (PDF)

Immunological Conservation between Epstein-Barr Virus and Herpes Simplex Virus

Journal of general virology, 1988-08, Vol.69 (8), p.2021-2031

1988

Volltextzugriff (PDF)

Transcriptional activation with concurrent or nonconcurrent template replication has differential effects on transient expression from herpes simplex virus promoters

Virus genes, 1989-03, Vol.2 (2), p.129-145

1989

Volltextzugriff (PDF)

Identification of the gB Homologues of Equine Herpesvirus Types 1 and 4 as Disulphide-linked Heterodimers and Their Characterization Using Monoclonal Antibodies

Journal of general virology, 1989-05, Vol.70 (5), p.1161-1172

1989

Volltextzugriff (PDF)

Transcriptional activation is not responsible for increased levels of autonomously expressed simian virus 40 T-antigen in herpes simplex virus-infected cells

Virus genes, 1989-05, Vol.2 (3), p.253-267

1989

Volltextzugriff (PDF)

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial

PloS one, 2014-08, Vol.9 (8), p.e104178-e104178

2014

Volltextzugriff (PDF)

Phase I Dose Escalation Trial Evaluating the Pharmacokinetics, Anti-Human Cytomegalovirus (HCMV) Activity, and Safety of 1263W94 in Human Immunodeficiency Virus-Infected Men with Asymptomatic HCMV Shedding

Antimicrobial Agents and Chemotherapy, 2002-09, Vol.46 (9), p.2969-2976

2002

Volltextzugriff (PDF)

Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine)

Open forum infectious diseases, 2024-07, Vol.11 (7), p.ofae383

2024

Volltextzugriff (PDF)

Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy

Clinical infectious diseases, 2013-07, Vol.57 (2), p.290-297

2013

Volltextzugriff (PDF)

A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine

Clinical infectious diseases, 2012-01, Vol.54 (2), p.285-293

2012

Volltextzugriff (PDF)

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months

Antiviral therapy, 2010-01, Vol.15 (3), p.297-305

2010

Volltextzugriff (PDF)

RANTES role in rheumatoid arthritis

The Lancet (British edition), 1994-02, Vol.343 (8896), p.547-548

1994

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Humans
(12)
Life Sciences & Biomedicine
(12)
Biological And Medical Sciences
(10)
Hiv Infections - Drug Therapy
(9)
Infectious Diseases
(8)
Antiviral Agents
(7)
Hiv
(7)
Human Immunodeficiency Virus
(7)
Microbiology
(7)
Medical Sciences
(6)
Virology
(6)
Adult
(5)
Aids
(5)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(5)
Female
(5)
Human Viral Diseases
(5)
Male
(5)
Pharmacology. Drug Treatments
(5)
Treatment Outcome
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

Distribution of HLA‐B alleles in a Ugandan HIV‐infected adult population: NORA pharmacogenetic substudy of DART

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial

HIV type 1 protease cleavage site mutations and viral fitness : Implications for drug susceptibility phenotyping assays

Identification of Cross-reacting Glycoproteins of Four Herpesviruses by Western Blotting

Expression of TAR RNA-Binding Protein in Baculovirus and Co-Immunoprecipitation with Insect Cell Protein Kinase

Expression of TAR RNA-Binding Protein in Baculovirus and Co-Immunoprecipitation with Insect Cell Protein Kinase

Antigenic and biochemical analysis of gB of herpes simplex virus type 1 and type 2 and of cross-reacting glycoproteins induced by bovine mammillitis virus and equine herpesvirus type 1

Immunological Conservation between Epstein-Barr Virus and Herpes Simplex Virus

Transcriptional activation with concurrent or nonconcurrent template replication has differential effects on transient expression from herpes simplex virus promoters

Identification of the gB Homologues of Equine Herpesvirus Types 1 and 4 as Disulphide-linked Heterodimers and Their Characterization Using Monoclonal Antibodies

Transcriptional activation is not responsible for increased levels of autonomously expressed simian virus 40 T-antigen in herpes simplex virus-infected cells

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial

Phase I Dose Escalation Trial Evaluating the Pharmacokinetics, Anti-Human Cytomegalovirus (HCMV) Activity, and Safety of 1263W94 in Human Immunodeficiency Virus-Infected Men with Asymptomatic HCMV Shedding

Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine)

Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy

A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months

RANTES role in rheumatoid arthritis

Suchergebnisse filtern